Strategy Asset Managers LLC Purchases 7,113 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Strategy Asset Managers LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 269.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,755 shares of the healthcare conglomerate’s stock after acquiring an additional 7,113 shares during the quarter. Strategy Asset Managers LLC’s holdings in UnitedHealth Group were worth $5,703,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $27,000. Macroview Investment Management LLC lifted its position in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the second quarter worth approximately $31,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC grew its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 2.2 %

NYSE:UNH opened at $576.93 on Wednesday. The firm has a 50-day simple moving average of $582.31 and a two-hundred day simple moving average of $551.25. The firm has a market cap of $530.94 billion, a P/E ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm posted $6.56 EPS. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on UNH shares. Truist Financial reiterated a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.